Production (Stage)
HCW Biologics Inc.
HCWB
$5.22
-$0.27-4.92%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -76.31% | 368.30% | -14.04% | -71.57% | 13.60% |
Total Receivables | -84.97% | -10.68% | -0.49% | -27.54% | -41.14% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -21.91% | -7.86% | -12.03% | -48.32% | -24.85% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 290.57% | 28.83% | -46.48% | -62.36% | 89.39% |
Total Current Assets | -66.75% | 172.10% | -12.22% | -61.57% | -3.05% |
|
|||||
Total Current Assets | -66.75% | 172.10% | -12.22% | -61.57% | -3.05% |
Net Property, Plant & Equipment | -0.64% | 0.33% | 0.12% | 0.95% | 10.45% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -49.56% |
Total Assets | -13.07% | 13.86% | -0.98% | -11.86% | 6.71% |
|
|||||
Total Accounts Payable | -11.63% | -1.47% | 34.30% | 60.84% | 70.15% |
Total Accrued Expenses | 19.53% | 5.50% | -85.03% | 112.99% | 19.99% |
Short-term Debt | -1.27% | -0.41% | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 1.61% | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -8.39% | -1.44% | 29.48% | 73.11% | 53.33% |
|
|||||
Total Current Liabilities | -8.39% | -1.44% | 29.48% | 73.11% | 53.33% |
Long-Term Debt | 4.44% | 14.16% | -34.72% | 19.65% | 31.25% |
Short-term Debt | -1.27% | -0.41% | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -5.83% | 1.32% | 10.28% | 52.72% | 44.08% |
|
|||||
Common Stock & APIC | 0.43% | 7.54% | 0.27% | 0.28% | 3.27% |
Retained Earnings | -2.18% | -3.47% | -4.18% | -19.59% | -10.59% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -26.47% | 32.09% | -58.25% | -172.08% | -35.07% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -26.47% | 32.09% | -58.25% | -172.08% | -35.07% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -26.47% | 32.09% | -58.25% | -172.08% | -35.07% |
|